Submitted by dcc on Wed, 2020-04-15 10:44 Study Title: A Phase I study of the ADAM-10 inhibitor, INCB7839 in children with recurrent/progressive high-grade gliomas to target microenvironmental neuroligin-3CIRB: Pediatric CIRBLead Group: PBTCStatus: ActiveReview Status: Available to Open
